GPCR/G protein
All GPCRs share a common seven trans-membrane structure. GPCRs are associated with heterotrimeric G-proteins which are GTP-binding proteins made of alpha, beta, and gamma subunits. When a ligand binds to GPCR, it activates the attached G-protein, the GDP is replaced with GTP. The activated G-protein then dissociates into an alpha and a beta-gamma complex which activates downstream signaling pathways. These intracellular signaling pathways include cAMP/PKA, calcium/NFAT, phospholipase C, protein tyrosine kinases, MAP kinases, PI-3-kinase, nitric oxide/cGMP, Rho, and JAK/STAT.
GPCRs are one of the most important therapeutic targets for various diseases, over 30% of all modern medicinal drugs target this family. Aberrant GPCR functions are involved in pathological conditions such as neurological, immunological and hormonal disorders. A large number of GPCRs have been identified, but whose ligands are not known, are classified as orphan receptors.
-
B5701 TC-G 1006Summary: sphingosine-1-phosphate receptor 1 (S1P1) agonist
-
B5755 CYM 5541Summary: sphingosine-1-phosphate receptor 3 (S1P3) allosteric agonist
-
B6707 Sphingosine-1-phosphateSummary: endogenous second messenger and ligand for S1PR1
-
B7038 JTE 013Summary: S1P receptor antagonist
-
B7001 SEW 2871Summary: sphingosine-1-phosphate 1 (S1P1) receptor agonist
-
B7441 CYM 5442 hydrochlorideSummary: S1P1 agonist, potent and selective
-
B7634 RP 001 hydrochlorideTarget: S1P receptorsSummary: S1P1 receptor agonist
-
B7658 TC-SP 14Summary: agonist of Sphingosine-1-Phosphate Receptor 1 (S1P1)
-
B7442 W146Summary: sphingosine-1-phosphate receptor S1P1 antagonist
-
B7611 VPC 230191 CitationSummary: S1P1/S1P3 receptor antagonist